What are the top competitors of ARAY in Healthcare sector?

The top competitors of ARAY in the Healthcare sector are: Delcath Systems, Inc. (DCTH), Envoy Medical, Inc. (COCHW).

Which has better valuations & earnings, ARAY or its competitors?

ARAY has a market cap of 125.7M and a Dividend Yield of N/A compared to its competitors.

Which stock is more profitable: ARAY or its competitors?

ARAY has an EPS of $-0.04, while DCTH has an EPS of $-0.45. So, ARAY is more profitable compared to DCTH.

What is ARAY stock volatility and risk in terms of investment?

ARAY has daily volatility of 3.23% as compared to its competitor DCTH which is 3.42%. ARAY is less volatile as compared to competitors and has low risk.

Is ARAY stock profitable?

ARAY has a Return on Equity (ROE) of 0.01%. So, ARAY is more profitable.

What is ARAY stock’s 52 weeks high and low?

ARAY stock has a 52-week high of ($2.95) and a low of ($1.14).

What was the average volume of ARAY stock?

The average volume of ARAY is (809.8K) in terms of investment.

Accuray Incorporated (ARAY) Competitors

Accuray Incorporated ARAY Peers

See (ARAY) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Specialties Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

Symbol	Price	Change %	Market Cap	P/E Ratio	EPS	Dividend Yield
ARAY	$1.22	-0.81%	125.7M	-30.50	-$0.04	N/A
DCTH	$13.83	-2.36%	481.5M	-30.72	-$0.45	N/A
COCHW	$0.04	+16.44%	36.1M	N/A	N/A	N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ARAY vs DCTH Comparison

ARAY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ARAY stands at 125.7M. In comparison, DCTH has a market cap of 481.5M. Regarding current trading prices, ARAY is priced at $1.22, while DCTH trades at $13.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ARAY currently has a P/E ratio of -30.50, whereas DCTH's P/E ratio is -30.72. In terms of profitability, ARAY's ROE is +0.01%, compared to DCTH's ROE of -0.35%. Regarding short-term risk, ARAY is less volatile compared to DCTH. This indicates potentially lower risk in terms of short-term price fluctuations for ARAY.

Accuray Incorporated